Cargando…

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?

Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity since it first entered the human population. This led to the emergence of numerous variants, some of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazarevic, Ivana, Pravica, Vera, Miljanovic, Danijela, Cupic, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310325/ https://www.ncbi.nlm.nih.gov/pubmed/34206453 http://dx.doi.org/10.3390/v13071192

Ejemplares similares

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

COVID-19 and the heart: what we have learnt so far
por: Shaha, Kunal Bikram, et al.
Publicado: (2020)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Implementation of the Nagoya Protocol in Livestock Sector: What Have We Learnt So Far?
por: Martyniuk, Elzbieta, et al.
Publicado: (2021)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
por: Braun, Fabian, et al.
Publicado: (2020)

Alcohol consumption during COVID-19 pandemic: What have we learnt so far?
por: Nogueira, V., et al.
Publicado: (2021)

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
por: Lazarevic, Ivana, et al.
Publicado: (2019)

Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far?
por: Handy, Richard D., et al.
Publicado: (2012)

What we have learnt (so far) about deliberative dialogue for evidence-based policymaking in West Africa
por: Ridde, Valéry, et al.
Publicado: (2017)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?
por: Corsetti, Maura, et al.
Publicado: (2019)

What we know so far
Publicado: (2021)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

How Does SARS-CoV-2 Affect Our Eyes—What Have We Learnt So Far about the Ophthalmic Manifestations of COVID-19?
por: Baj, Jacek, et al.
Publicado: (2022)

Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021)

What have we learnt from Covid?
por: Salter, Mark Steven
Publicado: (2021)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Neural synchrony within the motor system: what have we learned so far?
por: van Wijk, Bernadette C. M., et al.
Publicado: (2012)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Combining inclusive and exclusive data analyses-what have we learned so far?
por: Kittel, E W
Publicado: (1973)

Theory: Historical perspective and what have we learned from the Higgs so far
por: Ellis, Jonathan R.
Publicado: (2022)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far
por: Pacitti, Dario, et al.
Publicado: (2018)

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?
por: Walsh, Mary Norine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7al5ccmhdptiq8u186hn409elr